SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001318641-16-000012
Filing Date
2016-03-01
Accepted
2016-03-01 17:03:01
Documents
7
Period of Report
2015-12-31
Effectiveness Date
2016-03-01

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2016proxyfinal.htm DEF 14A 579237
2 a2015def14aasfiledimage2a01.jpg GRAPHIC 4925
3 a2015def14aasfiledimage5a01.jpg GRAPHIC 6450
4 a2015def14aasfiledimage6a01.jpg GRAPHIC 1010
5 a2015def14aasfiledimage8a01.jpg GRAPHIC 926
6 neillyonssignaturea01.jpg GRAPHIC 10564
7 yakovksignaturea01.jpg GRAPHIC 28748
  Complete submission text file 0001318641-16-000012.txt   648127
Mailing Address 73 HIGH STREET BUFFALO NY 14203
Business Address 73 HIGH STREET BUFFALO NY 14203 (716) 849-6810
CLEVELAND BIOLABS INC (Filer) CIK: 0001318641 (see all company filings)

IRS No.: 200077155 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-32954 | Film No.: 161474281
SIC: 8731 Services-Commercial Physical & Biological Research